Biol Reprod Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print October 26, 2005.
Biol Reprod 2005, 10.1095/biolreprod.105.043190
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
74/2/375    most recent
biolreprod.105.043190v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, J.
Right arrow Articles by Chen, D.-b.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, J.
Right arrow Articles by Chen, D.-b.
Agricola
Right arrow Articles by Zheng, J.
Right arrow Articles by Chen, D.-b.
BIOLOGY OF REPRODUCTION 74, 375–382 (2006)
DOI: 10.1095/biolreprod.105.043190
© 2006 by the Society for the Study of Reproduction, Inc.


Research Article

Exogenous Nitric Oxide Stimulates Cell Proliferation via Activation of a Mitogen-Activated Protein Kinase Pathway in Ovine Fetoplacental Artery Endothelial Cells1

Jing Zheng 2 3, YunXia Wen 3, Jason L. Austin 3, and Dong-bao Chen 4

Department of Obstetrics and Gynecology, Perinatal Research Laboratories,3 University of Wisconsin, Madison, Wisconsin 53715 Department of Reproductive Medicine, Division of Maternal-Fetal Medicine,4 University of California, San Diego, California 92093

ABSTRACT

Sodium nitroprusside (SNP), a nitric oxide (NO) donor and a nitrovasodilator drug used for patients with hypertensive crisis, has been shown to promote angiogenesis. However, direct evidence showing the involvement of NO in the SNP-induced angiogenesis is not available. Accordingly, we assessed whether NO generated from SNP-stimulated ovine fetoplacental artery endothelial (OFPAE) cell proliferation via activation of mitogen-activated protein kinase 3/1 (MAPK3/1, also termed ERK1/2). We observed that SNP dose dependently stimulated (P < 0.05) cell proliferation with a maximal effect at 1 µM and that SNP rapidly (≤15 min) phosphorylated (P < 0.05) MAPK3/1 but not v-akt murine thymoma viral oncogene homolog 1 (AKT1). Treatment of cells with SNP caused a rapid increase in NO levels in media. These increased NO levels were inhibited (P < 0.05) by 2-phenyl-4,4,5,5 tetramethylimidazoline-1-oxyl 3-oxide (PTIO), a NO scavenger. The SNP-induced cell proliferation and MAPK3/1 phosphorylation were attenuated (P < 0.05) by both PTIO and PD98059, a specific mitogen-activated protein kinase kinase 1 and 2 (MAP2K1/2, also termed MEK1/2) inhibitor. Using a semiquantitative RT-PCR analysis, we also showed that up to 12 h of treatment, SNP and NG-monomethyl-L-arginine (L-NMMA, a NOS inhibitor) did not alter mRNA expression of VEGF, FGF2, and their major receptors in OFPAE cells. The SNP's stimulatory effects on OFPAE cell proliferation and MAPK3/1 activation were confirmed in a human placental artery endothelial (HPAE) cell line. These data indicate that exogenous NO generated from SNP is able to stimulate fetoplacental artery endothelial cell proliferation at least partly via activation of the MAP2K1/2/MAPK3/1 cascade. These data also suggest that SNP could potentially be used to modulate placental angiogenesis.

cell proliferation, MAPK3/1, nitric oxide, placenta, placental endothelial cells, pregnancy, signal transduction, SNP


FOOTNOTES

1 Supported in part by National Institutes of Health grants HL64703 and HD38843S2 (J.Z.) and HL74947 and HL70562 (D.B.C.).

2 Correspondence: Jing Zheng, Department of Obstetrics and Gynecology, Perinatal Research Laboratories, University of Wisconsin, Atrium Basement Meriter Hospital, 202 S. Park St., Madison, WI 53715. FAX: 608 257 1304; jzheng{at}wisc.edu




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
J. Zheng, Y. Wen, Y. Song, K. Wang, D.-B. Chen, and R. R Magness
Activation of Multiple Signaling Pathways Is Critical for Fibroblast Growth Factor 2- and Vascular Endothelial Growth Factor-Stimulated Ovine Fetoplacental Endothelial Cell Proliferation
Biol Reprod, January 1, 2008; 78(1): 143 - 150.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
G. Wu, F. W. Bazer, J. M. Wallace, and T. E. Spencer
BOARD-INVITED REVIEW: Intrauterine growth retardation: Implications for the animal sciences
J Anim Sci, September 1, 2006; 84(9): 2316 - 2337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for the Study of Reproduction.